MicroRNA-208a is a Regulator of Cardiac Hypertrophy and Conduction in Mice
Overview
Authors
Affiliations
MicroRNAs (miRNAs) are a class of small noncoding RNAs that have gained status as important regulators of gene expression. Here, we investigated the function and molecular mechanisms of the miR-208 family of miRNAs in adult mouse heart physiology. We found that miR-208a, which is encoded within an intron of alpha-cardiac muscle myosin heavy chain gene (Myh6), was actually a member of a miRNA family that also included miR-208b, which was determined to be encoded within an intron of beta-cardiac muscle myosin heavy chain gene (Myh7). These miRNAs were differentially expressed in the mouse heart, paralleling the expression of their host genes. Transgenic overexpression of miR-208a in the heart was sufficient to induce hypertrophic growth in mice, which resulted in pronounced repression of the miR-208 regulatory targets thyroid hormone-associated protein 1 and myostatin, 2 negative regulators of muscle growth and hypertrophy. Studies of the miR-208a Tg mice indicated that miR-208a expression was sufficient to induce arrhythmias. Furthermore, analysis of mice lacking miR-208a indicated that miR-208a was required for proper cardiac conduction and expression of the cardiac transcription factors homeodomain-only protein and GATA4 and the gap junction protein connexin 40. Together, our studies uncover what we believe are novel miRNA-dependent mechanisms that modulate cardiac hypertrophy and electrical conduction.
Jimenez-Ortega R, Alejandre-Aguilar R, Rivas N, Sanchez F, Sanchez-Munoz F, Ballinas-Verdugo M Pathogens. 2025; 13(12.
PMID: 39770386 PMC: 11679500. DOI: 10.3390/pathogens13121127.
The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis.
Mlynarska E, Badura K, Kurcinski S, Sinkowska J, Jakubowska P, Rysz J Int J Mol Sci. 2024; 25(20).
PMID: 39456716 PMC: 11507602. DOI: 10.3390/ijms252010933.
The Role of Non-Coding RNAs in Regulating Cachexia Muscle Atrophy.
Chen G, Zou J, He Q, Xia S, Xiao Q, Du R Cells. 2024; 13(19.
PMID: 39404384 PMC: 11482569. DOI: 10.3390/cells13191620.
Lattanzi G, Dias M, Hashimoto D, Costa A, Neto S, Pazo F Mol Biol Rep. 2024; 51(1):1048.
PMID: 39388010 DOI: 10.1007/s11033-024-09960-1.
Progress and Challenges of Understanding Cardiorenal Syndrome Type 3.
Neres-Santos R, Armentano G, da Silva J, Falconi C, Carneiro-Ramos M Rev Cardiovasc Med. 2024; 24(1):8.
PMID: 39076878 PMC: 11270482. DOI: 10.31083/j.rcm2401008.